Holen Sie sich die Stockscreener-App
243.47
1.03%
2.49
Handel nachbörslich:
243.65
0.18
+0.07%
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Transfection Reagents and Equipment Market | Driving Gene - openPR.com
Global Gene Expression Analysis Market | RNA Sequencing & PCR - openPR.com
Bio-Rad extends anti-idiotypic antibody and SpyCatcher Reagent ranges for bioanalysis and antibody drug development - Cambridge Network
Global Gel Electrophoresis Equipment Market Surges Amid Rising - openPR.com
DNA Extraction Kits Market Future Business Opportunities - openPR.com
Protein Engineering Market Fueled by AI, Genomics, - openPR.com
Immunohistochemistry Market Trends | Cancer Diagnosis & - openPR.com
How to Take Advantage of moves in (BIO) - news.stocktradersdaily.com
Global Genomics Market Surges Toward USD 115.4 Billion - openPR.com
Genetic Testing Market Surges Amid Rising Demand - openPR.com
Immunohematology Market Booming with Increased Blood Screening Initiatives | Bio-Rad Laboratories, Immucor Inc. - openPR.com
Protein Analyzers Market Projected to Rise with Increased Focus - openPR.com
Biopharmaceutical Processing Equipment and Consumables - openPR.com
One Step RT-qPCR Kits Market Top Companies StudyTakara Bio - openPR.com
Analysts Offer Insights on Healthcare Companies: Bio-Rad Laboratories (BIO) and Ramsay Health Care (OtherRMSYF) - The Globe and Mail
Horseradish Peroxidase Market Size, Share & Trends | Industry - openPR.com
Cell Biology Market Set to Experience Research Technology - openPR.com
5 Analysts Have This To Say About Bio-Rad Laboratories - Nasdaq
Wells Fargo Lowers Price Target for Bio-Rad Laboratories (BIO) | BIO Stock News - GuruFocus
Europe Chromatography Resins Market Size, Outlook 2031 by Key - openPR.com
Wells Fargo Adjusts Price Target for Bio-Rad (BIO), Maintains Eq - GuruFocus
Food Diagnostics Market | Rapid Pathogen & Contaminant - openPR.com
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.
Cancer Monoclonal Antibodies Market in 2025-2032 Detailed - openPR.com
Next Generation Sequencing Market to Witness Upsurge in Growth - openPR.com
bio-rad laboratories stock highlighted in cantor fitzgerald report - Investing.com Australia
bio-rad laboratories stock highlighted in cantor fitzgerald report By Investing.com - Investing.com South Africa
Laboratory Proficiency Testing Market Set to Witness - openPR.com
Minimal Residual Disease Testing Market Set to Witness - openPR.com
Enzyme Linked Immunosorbent Assay Market reached US$ 2.14 - openPR.com
Flow Cytometry Market Growth, Trends & Forecast 2025 | Global - openPR.com
Immunohistochemistry Market Detailed in New Research Report - openPR.com
Here’s Why Bio-Rad Laboratories (BIO) Traded Lower in Q1 - Insider Monkey
Global Microarray Market Size, Share & Growth Forecast - openPR.com
How DNA Sequencing Is Revolutionizing Cancer Genomics and Rare - openPR.com
Cell Viability Assays Market 2025 | Techniques, Applications & - openPR.com
High Resolution Melting Analysis Market Detailed in New - openPR.com
Gel Documentation Systems Market Projected to Witness Massive - openPR.com
Cell Signaling Market in 2025-2032 Detailed Study Analysis with - openPR.com
Neuroscience Antibodies and Assays Market Trends, Growth & - openPR.com
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Learn to Evaluate (BIO) using the Charts - news.stocktradersdaily.com
Bio-Rad Laboratories (NYSE:BIO) Stock Rating Upgraded by Wall Street Zen - Defense World
1.18%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):